OLD Republic International Corp Has $63 Million Stock Holdings in Cardinal Health, Inc. $CAH

Key Points

• OLD Republic International Corp reduced its holdings in Cardinal Health by 8.5%, now owning 375,000 shares valued at approximately $63 million.
• Recent actions from other institutional investors include significant increases in stakes, with Nomura Holdings boosting its position by 138.7% in the fourth quarter.
• Cardinal Health's CEO recently sold 41,575 shares for over $6 million, indicating a 61.45% decrease in his ownership of the stock.

OLD Republic International Corp decreased its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 8.5% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 375,000 shares of the company's stock after selling 35,000 shares during the quarter. Cardinal Health accounts for approximately 2.5% of OLD Republic International Corp's holdings, making the stock its 13th biggest holding. OLD Republic International Corp owned 0.16% of Cardinal Health worth $63,000,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Nomura Holdings Inc. lifted its stake in shares of Cardinal Health by 138.7% during the fourth quarter. Nomura Holdings Inc. now owns 9,783 shares of the company's stock valued at $1,157,000 after acquiring an additional 5,684 shares during the period. Rafferty Asset Management LLC increased its stake in Cardinal Health by 11.0% in the 4th quarter. Rafferty Asset Management LLC now owns 27,444 shares of the company's stock valued at $3,246,000 after buying an additional 2,711 shares during the last quarter. Royal Bank of Canada grew its position in shares of Cardinal Health by 1.4% in the 4th quarter. Royal Bank of Canada now owns 744,599 shares of the company's stock valued at $88,064,000 after acquiring an additional 10,315 shares during the period. Toronto Dominion Bank raised its position in shares of Cardinal Health by 10.2% in the fourth quarter. Toronto Dominion Bank now owns 132,697 shares of the company's stock valued at $15,694,000 after purchasing an additional 12,236 shares during the period. Finally, Tidal Investments LLC boosted its position in shares of Cardinal Health by 23.9% in the fourth quarter. Tidal Investments LLC now owns 20,105 shares of the company's stock valued at $2,369,000 after acquiring an additional 3,882 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer owned 26,085 shares in the company, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michelle D. Greene sold 13,500 shares of the firm's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider owned 14,976 shares of the company's stock, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 over the last 90 days. 0.09% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Robert W. Baird raised their price objective on Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research note on Wednesday, August 13th. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $185.00 target price (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Argus set a $189.00 price objective on shares of Cardinal Health in a research report on Friday, August 22nd. Finally, Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research report on Tuesday, August 12th. Eleven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and a consensus target price of $165.93.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $150.45 on Tuesday. Cardinal Health, Inc. has a 1 year low of $106.54 and a 1 year high of $168.44. The firm's 50-day moving average is $154.16 and its two-hundred day moving average is $148.08. The stock has a market cap of $35.93 billion, a price-to-earnings ratio of 23.33, a PEG ratio of 1.29 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm's revenue was up .5% on a year-over-year basis. During the same period in the previous year, the company posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.63%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.